# FDA Inspection 1230771 - Biomat USA Inc - January 31, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2e8e273d-e543-4325-8b79-4b43921edaf2
Source feed: FDA_Inspections

> FDA Inspection 1230771 for Biomat USA Inc on January 31, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230771
- Company Name: Biomat USA Inc
- Inspection Date: 2024-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/biomat-usa-inc/04471073-df65-4a73-977f-94922fa07855

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d